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(2010) do raise the interesting question as
to how the presence of other AMPs,
which apparently have good direct anti-
S. aureus activity, is incapable of con-
trolling skin infections in AD.
Although recent studies have focused
on the regulation of AMPs by adaptive
immunity, it is not clear how the
relatively high expression of IL-22, a
key cytokine of adaptive immunity that
regulates AMPs, does not appear to
upregulate hBD-2 level in AD (Wolk
et al., 2004). hBD-2 has led the way in
studies of AMPs’ effects on adaptive
immunity (Yang et al., 1999). It binds
and attracts cells expressing the chemo-
kine receptor, CCR6 (Ro¨hrl et al., 2010).
A significant proportion of CCR6-expres-
sing T helper cells also produce IFN-g, IL-
17, and/or IL-22 (Ong and Leung, 2002;
Duhen et al., 2009). The increased and
decreased expression of IFN-g/IL-17 in
psoriatic and AD lesions, respectively
(Lowes et al., 2008) (Guttman-Yassky
et al., 2008), are not inconsistent with
the ability of hBD-2 to drive adaptive
immunity against skin infections. How-
ever, this hypothesis needs to be verified
further. As a proportion of AD patients are
not affected by skin infections (David and
Cambridge, 1986), it may be of interest to
evaluate whether there is any correlation
between hBD-2 level and clinical infec-
tion in AD. Further studies on the exact
role of hBD-2 in adaptive immunity are
needed before it is dismissed in relation
to the skin infections in AD.
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TO THE EDITOR
Bogh et al. (2010) recently found that
the increase in 25-(OH)-hydroxychole-
calciferol (25-(OH)-D) after UV-B ex-
posure in 28 non-sun-worshippers was
positively correlated with baseline total
cholesterol levels. In their discussion of
this interesting observation, the authors
cite from a biochemistry textbook:
The synthesis of vitamin D starts in
the bowel epithelial with the oxida-
tion of cholesterol from food or bile to
pro-vitamin D3 (7-dehydrocholester-
ol), which is then transported to the
skin, mainly the epidermis, wherein it
is isomerized to pre-vitamin D3
(cholecalciferol) by UVB radiation
(Champe et al., 2005).
A similar statement (regarding the
formation of 7-dehydrocholesterol in
the intestine and its transport to the
skin) is on page 732 in the most recent
(10th) edition of a German Pharmacol-
ogy textbook (Flockerzi, 2009).
Although we have no access to the
cited textbook of Champe et al. (2005),
in the textbook by Rang et al. (1995),
one can find on page 449:
Cholecalciferol (D3) generated in the
skin from 7-dehydrocholesterol by
the action of ultraviolet radiation,
the 7-dehydrocholesterol having
been formed from cholesterol in the
wall of the intestine.
A biochemistry textbook (Campbell
and Farrell, 2009) shows in Figure 8.30
Abbreviations: DHCR7, D-7-sterol reductase; HDL, high-density lipoprotein; HMG-CoA,
hydroxymethylglutaryl-CoA; LDL, low-density lipoprotein; 25-(OH)-D, 25-(OH)-hydroxycholecalciferol
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on page 224 an enzymatic reaction that
catalyzes the formation of 7-dehydro-
cholesterol from cholesterol. In the
paper by Pe´rez-Castrillo´n et al., 2007,
one can read on page 905:
Inhibition of the enzyme [i.e.: HMG-
CoA reductase] may increase levels
of 7-dehydrocholesterol and in-
crease the synthesis of 25-(OH)-
hydroxycholecalciferol.
This is cited by Bogh et al. (2010) as
follows:
Statin therapy inhibits the enzyme
hydroxymethylglutaryl-CoA (HMG-
CoA) reductase (Champe et al.,
2005), which is believed to increase
the level of 7-dehydrocholesterol, a
precursor of vitamin D.
Taken together, these statements
claim that
a. there is an enzymatic reaction,
occurring in the intestine wall or
bowel epithelia, converting (oxidiz-
ing) cholesterol to 7-dehydrocho-
lesterol;
b. 7-dehydrocholesterol is then trans-
ported to the skin via the blood-
stream;
c. inhibition of the hydroxymethyl-
glutaryl-CoA (HMG-CoA)-reductase
by statins increases the levels of
7-dehydrocholesterol.
In Goodman&Gilman’s 11th edition
(Friedman, 2006), however, on page
1652, one reads:
Ultraviolet irradiation of several ani-
mal and plant sterols results in their
conversion to compounds possessing
vitamin D activity. The principal
provitamin found in animal tissues is
7-dehydrocholesterol, which is
synthesized in the skin [emphasis by
us]. Exposure of the skin to sunlight
converts 7-dehydrocholesterol to cho-
lecalciferol (vitamin D3) [y].
We agree with the latter authors and
will take the opportunity to inform the
readers on the origin of the precursor
for vitamin D in the skin (Figure 1). The
last step in cholesterol biosynthesis
requires enzymatic reduction of the
D-7 double bond of 7-dehydrocholesterol
by a D-7-sterol reductase (DHCR7). The
human DHCR7 (EC 1.3.1.21) was first
cloned and functionally expressed by
Moebius et al. (1998). The enzyme,
which is abundant, for example, in the
liver, requires NADPH as a proton
donor and NADH cannot substitute.
DHCR7 contains putative sterol-sensing
domains (Bae et al., 1999). Any
7-dehydrocholesterol originating from
the gut would be rapidly converted to
cholesterol in the liver, never reaching
the systemic circulation. A physiologi-
cally occurring backward reaction from
cholesterol to 7-dehydrocholesterol,
catalyzed by either D-7-sterol reductase
or another enzyme, to the best of our
knowledge, has never been reported,
unless Figure 2 and Table 9 in Glover
et al. (1952) are accepted as solid proof.
It may have escaped some of the
textbooks that the epidermis is a very
active site of de novo cholesterol bio-
synthesis. Differentiated keratinocytes
have lost low-density lipoprotein (LDL)
receptors, but not high-density lipo-
protein (HDL) receptors (see Feingold
(2009) and the references cited herein).
They must synthesize sufficient choles-
terol for export through lamellar bodies
and a functioning lipid barrier. As each
molecule of cholesterol originates from
its precursor, 7-dehydrocholesterol, the
circulating 7-dehydrocholesterol cannot
have a significant role in the formation
of vitamin D. The human skin gradient
of 7-dehydrocholesterol increasing from
the dermis to the stratum spinosum
(Holick et al., 1980) also argues for this
conclusion.
Levels of 7-dehydrocholesterol in
the serum of healthy individuals are
around 0.3 mM and are apparently
directly correlated with the activity of
the HMG-CoA-reductase activity of the
liver (Axelson et al., 1998; de Sain-van
der Velden et al., 2008). Thus, statins
may decrease, but not increase, the
level of circulating 7-dehydrocholester-
ol. This view is supported by cell
culture experiments in which simvasta-
tin treatment increased the expression
of genes involved in cholesterol synth-
Acetyl-CoA
Multiple steps
Multiple steps
Squalene
Lathosterol
Lathosterol-5-desaturase
7-Dehydrocholesterol
(provitamin D)
AY 9944 7-Dehydrocholesterol reductase
Cholesterol
Cholesterol
Figure 1. Cholesterol biosynthesis in keratinocytes and provitamin D. Differentiated keratinocytes must
synthesize cholesterol de novo starting from acetyl-CoA.When squalene is formed, the first sterol intermediate,
all subsequent steps occur in the endoplasmic reticulum, the steroid being transferred from enzyme to enzyme
without leaving the membrane phase. The two last steps in the multiple-reaction pathway are shown.
A 5-desaturase (EC 1.3.3.2) catalyzes the insertion of a double bond into lathosterol (5-a-cholest-7en-3b-ol),
yielding 7-dehydrocholesterol (cholesta-5,7dien-3bol)¼ provitamin D. D-7-Sterol reductase (DHCR7) converts
provitamin D into cholesterol. Two inhibitors (AY-9944 and BM15.766) are often used to decrease the DHCR7
activity experimentally in cell culture or in animals and thereby increase the concentration of provitamin D.
Increased import of cholesterol by keratinocytes may also slow down DHCR7 activity.
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esis, including the D-7-sterol reductase
(Wassif et al., 2005).
In summary, the data of Bogh et al.
(2010) extend earlier observations of
the relationship between LDL to HDL
ratios and 25-(OH)-D (Carbone et al.,
2008). This points to a relationship
between systemic HDL and LDL cho-
lesterol levels and DHCR7 activity in
keratinocytes, perhaps via the sterol-
sensing domain of the enzyme.
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TO THE EDITOR
Acidification of the surface of the
stratum corneum (SC), the acid mantle,
was initially thought to be important
in the defense against infection. The
growth of pathogenic microorganisms,
such as Staphylococcus aureus and
Streptococcus pyogenes, is inhibited
by an acidic skin pH whereas the
growth of resident (normal) skin flora
is stimulated (Puhvel et al., 1975;
Korting et al., 1990, 1992). However,
recent studies have shown that acidifi-
cation of the SC has additional func-
tions, including regulating several
key SC functions. A major function of
the skin is to form a permeability barrier
between the dry external environment
and the moist interior of the body (Elias,
2007). This permeability barrier resides
in the extracellular lipid membranes of
the SC, and studies have shown that an
acidified SC is required for the forma-
tion of a functionally competent perme-
ability barrier (Mauro et al., 1998; Fluhr
et al., 2001; Hachem et al., 2003).
Specifically, in the SC b-glucocerebro-
sidase and acid sphingomyelinase
metabolize glucosylceramides and
sphingomyelin, respectively, to cera-
mides, which is the major family of
lipids in the extracellular membranes
that mediate permeability barrier func-
tion (Feingold, 2007). Both the enzymes
require an acidic milieu for optimal
enzymatic activity; hence, when the pH
of the SC increases, the metabolism of
glucosylceramides and sphingomyelin
to ceramides is impaired, resulting
in abnormal permeability barrier home-
ostasis (Holleran et al., 1992, 1993;
Feingold, 2007). In addition, an acidic
SC pH inhibits the activity of serine
proteases thereby maintaining the
cohesiveness and integrity of the SC
(Hachem et al., 2005). With an increase
in SC pH, the activities of these serine
proteases are stimulated resulting in the
degradation of corneodesmosomes and
a decrease in SC integrity and cohesion
(Fluhr et al., 2004b; Hachem et al.,
2005). Thus, an acidic SC is important
in regulating the metabolism and func-
tion of the SC, and alterations in SC pH
could have numerous adverse effects.
A variety of different pathways are
postulated to contribute to the acid mantleAbbreviation: SC, stratum corneum
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Role of Histidase in SC Acidification
